tiprankstipranks
Advertisement
Advertisement
Transcenta Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend
PremiumCompany AnnouncementsTranscenta Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend
2M ago
Transcenta Tightens Costs and Bolsters Liquidity Ahead of Oppenheimer Conference
Premium
Company Announcements
Transcenta Tightens Costs and Bolsters Liquidity Ahead of Oppenheimer Conference
3M ago
Transcenta Advances Dealmaking, Licensing and Financing to Resolve Audit Disclaimer and Bolster Liquidity
Premium
Company Announcements
Transcenta Advances Dealmaking, Licensing and Financing to Resolve Audit Disclaimer and Bolster Liquidity
4M ago
Transcenta Holding Limited Announces Auditor Change to Ernst & Young
PremiumCompany AnnouncementsTranscenta Holding Limited Announces Auditor Change to Ernst & Young
6M ago
Transcenta’s Partner Inhibrx Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma
Premium
Company Announcements
Transcenta’s Partner Inhibrx Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma
7M ago
Transcenta Advances Financial and Strategic Initiatives to Strengthen Position
Premium
Company Announcements
Transcenta Advances Financial and Strategic Initiatives to Strengthen Position
7M ago
Transcenta Holding Limited Schedules Board Meeting to Review Interim Results
PremiumCompany AnnouncementsTranscenta Holding Limited Schedules Board Meeting to Review Interim Results
9M ago
Transcenta Implements Strategic Measures to Enhance Financial Stability and Pipeline Development
Premium
Company Announcements
Transcenta Implements Strategic Measures to Enhance Financial Stability and Pipeline Development
11M ago
Transcenta Clarifies Option Grant to Consultant Dr. Caroline Germa
Premium
Company Announcements
Transcenta Clarifies Option Grant to Consultant Dr. Caroline Germa
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100